D. Western Therapeutics Institute (FRA:6DW) Cyclically Adjusted Book per Share: €0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6DW D. Western Therapeutics Institute Inc FRA:6DW
49 GF Score
Price €0.42
GF Value €0.32
! 3 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute Cyclically Adjusted Book per Share?

D. Western Therapeutics Institute FRA:6DW -1.42% 49 Cyclically Adjusted Book per Share is €0.00 as of Jun. 2026. GuruFocus rates FRA:6DW with a GF Score™ of 49/100 and a GF Value™ of €0.32. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

D. Western Therapeutics Institute's adjusted book value per share for the three months ended in Jun. 2026 was €0.137. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, D. Western Therapeutics Institute's average Cyclically Adjusted Book Growth Rate was -8.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -4.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of D. Western Therapeutics Institute was 4.10% per year. The lowest was -4.30% per year. And the median was 2.40% per year.

As of today (2026-08-22), D. Western Therapeutics Institute's current stock price is €0.416. D. Western Therapeutics Institute's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €0.00. D. Western Therapeutics Institute's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of D. Western Therapeutics Institute was 9.06. The lowest was 0.86. And the median was 2.72.


D. Western Therapeutics Institute  (FRA:6DW) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of D. Western Therapeutics Institute was 9.06. The lowest was 0.86. And the median was 2.72.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


D. Western Therapeutics Institute Cyclically Adjusted Book per Share Related Terms


D. Western Therapeutics Institute Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Cyclically Adjusted Book per Share Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.54 0.46 0.43 0.34

D. Western Therapeutics Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.38 0.34 0.00 0.00

FRA:6DW vs VRTX, REGN, RVMD: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, D. Western Therapeutics Institute's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


D. Western Therapeutics Institute Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D. Western Therapeutics Institute's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where D. Western Therapeutics Institute's Cyclically Adjusted PB Ratio falls into.


FRA:6DW
49GF Score
D. Western Therapeutics Institute Inc FRA:6DW
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, D. Western Therapeutics Institute's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.137/113.6000*113.6000
=0.137

Current CPI (Jun. 2026) = 113.6000.

D. Western Therapeutics Institute Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.983 98.100 1.138
201609 0.991 98.000 1.149
201612 0.904 98.400 1.044
201703 1.081 98.100 1.252
201706 0.713 98.500 0.822
201709 0.643 98.800 0.739
201712 0.570 99.400 0.651
201803 0.529 99.200 0.606
201806 0.487 99.200 0.558
201809 0.419 99.900 0.476
201812 0.376 99.700 0.428
201903 0.428 99.700 0.488
201906 0.435 99.800 0.495
201909 0.443 100.100 0.503
201912 0.437 100.500 0.494
202003 0.432 100.300 0.489
202006 0.411 99.900 0.467
202009 0.629 99.900 0.715
202012 0.586 99.300 0.670
202103 0.564 99.900 0.641
202106 0.543 99.500 0.620
202109 0.540 100.100 0.613
202112 0.531 100.100 0.603
202203 0.518 101.100 0.582
202206 0.458 101.800 0.511
202209 0.437 103.100 0.482
202212 0.421 104.100 0.459
202303 0.418 104.400 0.455
202306 0.370 105.200 0.400
202309 0.325 106.200 0.348
202312 0.254 106.800 0.270
202403 0.183 107.200 0.194
202406 0.152 108.200 0.160
202412 0.109 110.700 0.112
202503 0.137 111.100 0.140
202506 0.116 111.700 0.118
202509 0.160 112.000 0.162
202512 0.145 113.000 0.146
202603 0.131 112.700 0.132
202606 0.137 113.600 0.137

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.00 mean?
D. Western Therapeutics Institute (FRA:6DW) has a Cyclically Adjusted Book per Share of €0.00 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on D. Western Therapeutics Institute and its competitors.
Is D. Western Therapeutics Institute's Cyclically Adjusted Book per Share too high?
D. Western Therapeutics Institute's current Cyclically Adjusted Book per Share is €0.00. Overall, D. Western Therapeutics Institute has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's Cyclically Adjusted Book per Share compare to VRTX and REGN?
D. Western Therapeutics Institute's Cyclically Adjusted Book per Share of €0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Cyclically Adjusted Book per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
D. Western Therapeutics Institute (FRA:6DW) has a current Cyclically Adjusted Book per Share of €0.00. The stock's GF Value™ is €0.32, compared to a current price of €0.42 — trading 30% above its estimated fair value. The current Cyclically Adjusted Book per Share is €0.00. D. Western Therapeutics Institute's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For D. Western Therapeutics Institute (FRA:6DW), the current Cyclically Adjusted Book per Share is €0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (FRA:6DW) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of €0.42 is trading 30% above its estimated GF Value™ of €0.32.

Key valuation signals for FRA:6DW:

  • Cyclically Adjusted Book per Share: €0.00
  • GF Value™: €0.32 vs. price of €0.42 (30% above fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the FRA:6DW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


D. Western Therapeutics Institute Business Description

Other Exchanges 4576:Japan
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
49GF Score

Get the complete analysis for FRA:6DW

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.42
Price
€0.32
GF Value